Therapy of chronic end-stage heart failure: where do we go?
Christiansen
S
S
Autschbach
R
R
D002317:Cardiovascular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002908:Chronic Disease; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D005355:Fibrosis / Q000188:drug therapy; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology / Q000601:surgery*; D016027:Heart Transplantation; D006801:Humans; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D018579:Patient Selection; D014850:Waiting Lists
D002317:Cardiovascular Agents; D016326:Extracellular Matrix Proteins